Looking to publish in European Neuropsychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginEuropean Neuropsychopharmacology is the official journal of the European College of Neuropsychopharmacology and focuses on clinical and basic science contributions that advance understanding of brain function and human behaviour, with emphasis on translating neuroscience and genomics findings into improved psychiatric treatments and public health impact.
Looking to publish in European Neuropsychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
European Neuropsychopharmacology accepts the following article types. Click on an article type to view submission instructions.
Full Length Research Papers
Reviews On Specialised Topics
Short Communications
Letters To The Editor
Insights Papers
Recent Publications
Association of plasmatic lipids and suicidal ideation in bipolar disorders: a FACE-BD cohort study
A. Frajerman, Y. Dansou, A. Lengvenyte, E. Olié, K. M Bailara, F. Bellivier, P. Courtet, C. Dubertret, B. Etain, S. Gard, E. Haffen, D. Januel, A Lefrere, M. Polosan, P. Roux, L. Samalin, R. Schwan, D Szekely, A. Yrondi, M. Leboyer, B. Chaumette, O. Godin
From real-world experience to precision prescribing of antidepressants: a machine-learning analysis of clinicians’ treatment choices
Francesco Calabrò, Claudio Caiazza, Umberto Albert, Bernardo Maria Dell’Osso, Maurizio Pompili, Gabriele Sani, Maria Auricchio, Carlo Ignazio Cattaneo, Vassilis Martiadis, Flavia Rossano, Felicia Russo, Claudia Toni, Claudio Vampini, Umberto Volpe, Andrea Fiorillo
Psychedelics and suicidality: A double-edged sword - risks, mechanisms, and moving forward
Maia Mallevays, Lucie Berkovitch
The average patient does not exist: Antidepressant evidence and the individual case
Stefan Jerotic, Anna Julia Krupa
Social cognitive impairment across the bipolar disorder continuum: A comparative study of high-risk, first-episode, and chronic groups
Ezgi Cesim, Yaren Ecesu Turan, Özge İlhan, Muhammed Demir, Aybüke Küçükakdağ, Simge Uzman Özbek, Merve Sümeyye Eyüboğlu, Burcu Verim, Ekin Süt, Berna Yalınçetin, Emre Bora
Frequently asked questions
How long does it take to publish?
45 days from submission to decision after review; 33 days from submission to acceptance.
Reformat to European Neuropsychopharmacology using Livewrite PremiumIs a cover letter required?
A covering letter must accompany all submissions.
Reformat to European Neuropsychopharmacology using Livewrite PremiumWhat are the publication costs?
USD 3000 excl. taxes for open access articles; no open access publication fee for subscription articles.
Reformat to European Neuropsychopharmacology using Livewrite Premium